These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3572753)

  • 1. Relationship between planar and all-surface rate constants for drugs formulated in nondisintegrating cylindrical slow-release tablets.
    Jambhekar SS; Makoid MC; Cobby J
    J Pharm Sci; 1987 Feb; 76(2):146-8. PubMed ID: 3572753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH- and flow-rate-independent release of drug from uncoated slow-release tablets.
    Jambhekar SS; Cobby J
    J Pharm Sci; 1985 Sep; 74(9):991-4. PubMed ID: 4067855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical models for the release of drugs from matrix tablets.
    Cobby J
    J Biomed Mater Res; 1978 Sep; 12(5):627-34. PubMed ID: 701299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution of solid dosage form. II. Equations for the dissolution of nondisintegrating tablet under the sink condition.
    Yonezawa Y; Shirakura K; Otsuka A; Sunada H
    Chem Pharm Bull (Tokyo); 1991 Mar; 39(3):769-72. PubMed ID: 2070463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of nifedipine from mucoadhesive tablets of its inclusion complexes with beta-cyclodextrin.
    Chowdary KP; Kamalakara RG
    Pharmazie; 2003 Oct; 58(10):721-4. PubMed ID: 14609284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of quinidine in slow-release form. A comparison between two preparations containing quinidine bisulphate as the active constituent.
    Regårdh CG; Johnsson G; Lundborg P; Perrson BA
    Arzneimittelforschung; 1977; 27(9):1716-8. PubMed ID: 21671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation into the erosion behaviour of a high drug-load (85%) particulate system designed for an extended-release matrix tablet. Analysis of erosion kinetics in conjunction with variations in lubrication, porosity and compaction rate.
    Dürig T; Venkatesh GM; Fassihi R
    J Pharm Pharmacol; 1999 Oct; 51(10):1085-92. PubMed ID: 10579678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man.
    Leucuta SE
    Pharmazie; 1988 Dec; 43(12):845-8. PubMed ID: 3247376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of controlled-release and enteric-coated formulations of sodium salicylate.
    Borgström L; Ekman B; Larsson H; Leden I; Lindahl A; Melander A; Wåhlin-Boll E
    Biopharm Drug Dispos; 1984; 5(3):261-72. PubMed ID: 6487753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model for the drug release from a polymer matrix tablet--effects of swelling and dissolution.
    Borgquist P; Körner A; Piculell L; Larsson A; Axelsson A
    J Control Release; 2006 Jul; 113(3):216-25. PubMed ID: 16797098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Water uptake of tablets, their disintegration and dissolution are in close relation].
    Miseta M; Pintyéné Hódi K; Szabóné Révész P
    Acta Pharm Hung; 1995 Mar; 65(2):33-9. PubMed ID: 7793287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of two commercial potassium chloride tablets for slow-release in an in vitro dissolution test].
    Wu PC; Huang YB; Chang SJ; Ko HM; Tsai YH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Mar; 8(3):161-7. PubMed ID: 1560473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
    Taggart WV; Holyoak W
    Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Square root of time dependence of matrix formulations with low drug content.
    Fessi H; Marty JP; Puisieux F; Carstensen JT
    J Pharm Sci; 1982 Jul; 71(7):749-52. PubMed ID: 7120057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies on eight dissolution method using 21 commercial chloramphenicol tablets and a nondisintegrating benzoic acid tablet.
    Ogata H; Shibazaki T; Inoue T; Ejima A
    J Pharm Sci; 1979 Jun; 68(6):708-12. PubMed ID: 458569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of internal structure on kinetics of drug release from wax matrix tablets.
    Ishino R; Yoshino H; Hirikawa Y; Noda K
    Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3440-5. PubMed ID: 2092942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution kinetics and physical characterization of three-layered tablet with poly(ethylene oxide) core matrix capped by Carbopol.
    Hong SI; Oh SY
    Int J Pharm; 2008 May; 356(1-2):121-9. PubMed ID: 18272308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution characteristics of cylindrical particles and tablets.
    Fukunaka T; Yaegashi Y; Nunoko T; Ito R; Golman B; Shinohara K
    Int J Pharm; 2006 Mar; 310(1-2):146-53. PubMed ID: 16414218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution kinetics of soluble nondisintegrating disks.
    de Blaey CJ; van der Graaff H
    J Pharm Sci; 1977 Dec; 66(12):1696-9. PubMed ID: 925932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.